These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 35994281)
1. Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection. Desai AN; Thompson GR; Neumeister SM; Arutyunova AM; Trigg K; Cohen SH JAMA; 2022 Oct; 328(13):1348-1350. PubMed ID: 35994281 [TBL] [Abstract][Full Text] [Related]
2. Can a smallpox drug treat monkeypox? Compassionate use of tecovirimat for monkeypox infection. Fatima M; Ahmed A; Murad MW; Afzal Z Eur J Intern Med; 2023 Jan; 107():105-106. PubMed ID: 36153182 [No Abstract] [Full Text] [Related]
3. Tecovirimat and the Treatment of Monkeypox - Past, Present, and Future Considerations. Sherwat A; Brooks JT; Birnkrant D; Kim P N Engl J Med; 2022 Aug; 387(7):579-581. PubMed ID: 35921403 [No Abstract] [Full Text] [Related]
11. Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques. Russo AT; Grosenbach DW; Brasel TL; Baker RO; Cawthon AG; Reynolds E; Bailey T; Kuehl PJ; Sugita V; Agans K; Hruby DE J Infect Dis; 2018 Sep; 218(9):1490-1499. PubMed ID: 29982575 [TBL] [Abstract][Full Text] [Related]
12. Progression of human monkeypox infection despite tecovirimat in an immunocompromised adult. Dammann F; Raja M; Camargo JF Transpl Infect Dis; 2023 Feb; 25(1):e14022. PubMed ID: 36714983 [TBL] [Abstract][Full Text] [Related]
13. Monkeypox treatment: Current evidence and future perspectives. Khani E; Afsharirad B; Entezari-Maleki T J Med Virol; 2023 Jan; 95(1):e28229. PubMed ID: 36253931 [TBL] [Abstract][Full Text] [Related]
14. A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome. Viguier C; de Kermel T; Boumaza X; Benmedjahed NS; Izopet J; Pasquier C; Delobel P; Mansuy JM; Martin-Blondel G Int J Infect Dis; 2022 Dec; 125():135-137. PubMed ID: 36397606 [TBL] [Abstract][Full Text] [Related]
15. Tecovirimat, a p37 envelope protein inhibitor for the treatment of smallpox infection. Duraffour S; Andrei G; Snoeck R IDrugs; 2010 Mar; 13(3):181-91. PubMed ID: 20191435 [TBL] [Abstract][Full Text] [Related]
16. Oral Tecovirimat for the Treatment of Smallpox. Grosenbach DW; Honeychurch K; Rose EA; Chinsangaram J; Frimm A; Maiti B; Lovejoy C; Meara I; Long P; Hruby DE N Engl J Med; 2018 Jul; 379(1):44-53. PubMed ID: 29972742 [TBL] [Abstract][Full Text] [Related]
17. Lack of clinical evidence of antiviral therapy for human monkeypox: A scoping review. Kuroda N; Shimizu T; Hirano D; Ishikane M; Kataoka Y J Infect Chemother; 2023 Feb; 29(2):228-231. PubMed ID: 36283609 [TBL] [Abstract][Full Text] [Related]
18. Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246. Huggins J; Goff A; Hensley L; Mucker E; Shamblin J; Wlazlowski C; Johnson W; Chapman J; Larsen T; Twenhafel N; Karem K; Damon IK; Byrd CM; Bolken TC; Jordan R; Hruby D Antimicrob Agents Chemother; 2009 Jun; 53(6):2620-5. PubMed ID: 19349521 [TBL] [Abstract][Full Text] [Related]
19. Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol - United States, May-August 2022. O'Laughlin K; Tobolowsky FA; Elmor R; Overton R; O'Connor SM; Damon IK; Petersen BW; Rao AK; Chatham-Stephens K; Yu P; Yu Y; MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(37):1190-1195. PubMed ID: 36107794 [TBL] [Abstract][Full Text] [Related]